COVID-19 and Antibiotic Resistance

The coronavirus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge we have faced since World War Two. During the current COVID-19 pandemic there are potential threats that could affect antimicrobial stewardship activities and drive antimicrobial resistance. The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population. Patients hospitalized as a result of the virus are being given a combination of medications to prevent possible secondary bacterial infections.

Antibiotics underpin all of modern medicine, but AMR is an issue that could impact millions of lives in the decades to come. Currently, the COVID-19 pandemic is causing immense suffering and loss of life across the globe, but AMR has been and will remain one of the most significant threats to global human health.

  • COVID-19
  • AMR
  • Antibiotics
  • Antimicrobial stewardship

Related Conference of COVID-19 and Antibiotic Resistance

January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France

COVID-19 and Antibiotic Resistance Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in